GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioteque Corp (ROCO:4107) » Definitions » Operating Cash Flow per Share

Bioteque (ROCO:4107) Operating Cash Flow per Share : NT$10.23 (TTM As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Bioteque Operating Cash Flow per Share?

Bioteque's operating cash flow per share for the three months ended in Sep. 2024 was NT$1.88. Bioteque's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was NT$10.23.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Bioteque was -1.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 2.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Bioteque's Operating Cash Flow per Share or its related term are showing as below:

ROCO:4107' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -18.9   Med: 10.4   Max: 31.6
Current: 2.3

During the past 13 years, Bioteque's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.60% per year. The lowest was -18.90% per year. And the median was 10.40% per year.

ROCO:4107's 3-Year OCF Growth Rate is ranked worse than
51.47% of 682 companies
in the Medical Devices & Instruments industry
Industry Median: 3.35 vs ROCO:4107: 2.30

Bioteque Operating Cash Flow per Share Historical Data

The historical data trend for Bioteque's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioteque Operating Cash Flow per Share Chart

Bioteque Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.96 9.12 6.74 9.26 9.76

Bioteque Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.14 3.48 2.53 2.34 1.88

Competitive Comparison of Bioteque's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Bioteque's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioteque's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bioteque's Price-to-Operating-Cash-Flow falls into.



Bioteque Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Bioteque's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=679.375/69.624
=9.76

Bioteque's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )=Cash Flow from Operations (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=130.905/69.481
=1.88

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$10.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioteque Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Bioteque's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioteque Business Description

Traded in Other Exchanges
N/A
Address
Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.

Bioteque Headlines

No Headlines